[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 1092 Introduced in Senate (IS)]







106th CONGRESS
  1st Session
                                S. 1092

   To amend the Federal Food, Drug, and Cosmetic Act with respect to 
           regulation of pharmacists, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 20, 1999

   Mr. Crapo introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
   To amend the Federal Food, Drug, and Cosmetic Act with respect to 
           regulation of pharmacists, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pharmacist's Patients Protection Act 
of 1999''.

SEC. 2. FUNDING OF REGULATION.

    Chapter IX of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
391 et seq.) is amended by adding at the end the following:

``SEC. 908. FUNDING.

    ``None of the funds appropriated or made available to the Food and 
Drug Administration may be used to implement--
            ``(1) the proposed rule entitled `Prescription Drug Product 
        Labeling; Medication Guide Requirements', published in the 
        Federal Register on August 24, 1995, 60 Fed. Reg. 44182 (to be 
        codified at parts 201, 208, 314, and 601, Code of Federal 
        Regulations);
            ``(2) the final rule entitled `Prescription Drug Product 
        Labeling; Medication Guide Requirements', published in the 
        Federal Register on December 1, 1998, 63 Fed. Reg. 66378 (to be 
        codified at parts 201, 208, 314, 601, and 610, Code of Federal 
        Regulations); or
            ``(3) any corresponding similar regulation or ruling 
        (including a policy statement or guideline).''.
                                 <all>